CME Group Inc. (NASDAQ:CME) Shares Bought by Mount Yale Investment Advisors LLC

Mount Yale Investment Advisors LLC increased its stake in CME Group Inc. (NASDAQ:CME) by 4.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,088 shares of the financial services provider’s stock after acquiring an additional 398 shares during the period. Mount Yale Investment Advisors LLC’s holdings in CME Group were worth $2,226,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Capital International Investors boosted its holdings in CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after acquiring an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. grew its holdings in shares of CME Group by 137.6% during the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the period. M&G Plc acquired a new stake in CME Group during the 1st quarter worth approximately $156,631,000. Assenagon Asset Management S.A. lifted its position in CME Group by 577.9% during the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after buying an additional 550,133 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its stake in CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. The Goldman Sachs Group lifted their target price on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Bank of America upped their target price on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. TD Cowen assumed coverage on CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 target price on the stock. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a report on Tuesday, October 8th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $222.07.

CME Group Stock Up 1.1 %

CME Group stock opened at $229.69 on Friday. The company’s 50-day moving average price is $218.08 and its two-hundred day moving average price is $208.66. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market cap of $82.70 billion, a price-to-earnings ratio of 26.13, a PEG ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.36.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the firm earned $2.25 EPS. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. On average, analysts expect that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.00%. CME Group’s payout ratio is currently 52.33%.

Insider Activity at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.